高水平儿茶酚胺与妊娠并发症的 相关性研究进展
Correlation Analysis between High Level Catecholamines Excess and Pregnancy Complications
DOI: 10.12677/acm.2026.1662275, PDF,   
作者: 陈文轩：重庆医科大学，重庆；董晓静*：重庆医科大学附属第二医院妇产科，重庆
关键词: 儿茶酚胺；妊娠并发症；子痫前期；胎儿生长受限；Catecholamines； Pregnancy Complications； Preeclampsia； Fetal Growth Restriction
摘要: 妊娠并发症是全球孕产妇和围产儿发病及死亡的主要原因，孕妇机体儿茶酚胺水平过高与妊娠并发症的发生显著相关，本综述将对孕妇机体高儿茶酚胺水平与妊娠并发症的相关性研究进展作一概述。
Abstract: Pregnancy complications are a leading cause of maternal and perinatal morbidity and mortality worldwide. Excessive catecholamines levels in pregnant women are significantly associated with the occurrence of pregnancy complications. This review provides an overview of the research progress on the correlation between catecholamines excess and pregnancy complications.
文章引用：陈文轩, 董晓静. 高水平儿茶酚胺与妊娠并发症的 相关性研究进展[J]. 临床医学进展, 2026, 16(6): 765-770. https://doi.org/10.12677/acm.2026.1662275

参考文献

[1] Barrell, A.M. and Sferruzzi‐Perri, A.N. (2025) The Impact of Preeclampsia and Gestational Diabetes on Future Maternal Cardiometabolic Health. Acta Physiologica, 241, e70113. [Google Scholar] [CrossRef] 
[2] Horackova, H., Vachalova, V., Abad, C., Karahoda, R. and Staud, F. (2023) Perfused Rat Term Placenta as a Preclinical Model to Investigate Placental Dopamine and Norepinephrine Transport. Clinical Science, 137, 149-161. [Google Scholar] [CrossRef] [PubMed]
[3] Lopez, A., Duparc, C., Renouf, S., Machevin, E., Le Guillou, V., Sabourin, J., et al. (2022) Expression of LHCGR in Pheochromocytomas Unveils an Endocrine Mechanism Connecting Pregnancy and Epinephrine Overproduction. Hypertension, 79, 1006-1016. [Google Scholar] [CrossRef] [PubMed]
[4] Lin, C., Mazzuca, M.Q. and Khalil, R.A. (2024) Increased Uterine Arterial Tone, Stiffness and Remodeling with Augmented Matrix Metalloproteinase-1 and-7 in Uteroplacental Ischemia-Induced Hypertensive Pregnancy. Biochemical Pharmacology, 228, Article 116227. [Google Scholar] [CrossRef] [PubMed]
[5] Binder, J., Palmrich, P., Sugulle, M., Kalafat, E., Schirwani-Hartl, N., Khalil, A., et al. (2026) Effects of Antihypertensive Therapy on Pre-and Postnatal Maternal Hemodynamics. Hypertension, 83, e26126. [Google Scholar] [CrossRef] 
[6] Schwartz, K.S., Campbell, N., Jalal, D.I. and Stanhewicz, A.E. (2025) Reductions in Angiotensin II Type 2 Receptor-Mediated Vasodilation Contribute to Increased Angiotensin II Vasoconstrictor Sensitivity in Women with Preeclampsia History. Clinical Science, 139, 545-558. [Google Scholar] [CrossRef] [PubMed]
[7] Mazzuca, M.Q., Buyukcelebi, K., Lin, C. and Khalil, R.A. (2023) Increased Ca2+-Dependent Intrinsic Tone and Arterial Stiffness in Mesenteric Microvessels of Hypertensive Pregnant Rats. Biochemical Pharmacology, 208, Article 115353. [Google Scholar] [CrossRef] [PubMed]
[8] Morella, I.M., Brambilla, R. and Morè, L. (2022) Emerging Roles of Brain Metabolism in Cognitive Impairment and Neuropsychiatric Disorders. Neuroscience & Biobehavioral Reviews, 142, Article 104892. [Google Scholar] [CrossRef] [PubMed]
[9] Qin, T.C.T. and Ma, R. (2024) Stress Hormones: Unveiling the Role in Accelerated Cellular Senescence. Aging and Disease, 16, 1946-1970.
[10] Chen, Q., He, J., Liu, H., Huang, Q., Wang, S., Yin, A., et al. (2023) Small Extracellular Vesicles-Transported LncRNA TDRKH-AS1 Derived from AOPPs-Treated Trophoblasts Initiates Endothelial Cells Pyroptosis through PDIA4/DDIT4 Axis in Preeclampsia. Journal of Translational Medicine, 21, Article No. 496. [Google Scholar] [CrossRef] [PubMed]
[11] Decrue, F., Townsend, R., Miller, M.R., Newby, D.E. and Reynolds, R.M. (2023) Ambient Air Pollution and Maternal Cardiovascular Health in Pregnancy. Heart, 109, 1586-1593. [Google Scholar] [CrossRef] [PubMed]
[12] Fato, B.R., de Alwis, N., Beard, S., Binder, N.K., Pritchard, N., Kaitu’u-Lino, T.J., et al. (2024) Exploring the Therapeutic Potential of C-Type Natriuretic Peptide for Preeclampsia. Hypertension, 81, 1883-1894. [Google Scholar] [CrossRef] [PubMed]
[13] Gao, Q., Tang, J., Li, N., Liu, B., Zhang, M., Sun, M., et al. (2018) What Is Precise Pathophysiology in Development of Hypertension in Pregnancy? Precision Medicine Requires Precise Physiology and Pathophysiology. Drug Discovery Today, 23, 286-299. [Google Scholar] [CrossRef] [PubMed]
[14] Burton, G.J. and Jauniaux, E. (2018) Pathophysiology of Placental-Derived Fetal Growth Restriction. American Journal of Obstetrics and Gynecology, 218, S745-S761. [Google Scholar] [CrossRef] [PubMed]
[15] Salavati, N., Smies, M., Ganzevoort, W., Charles, A.K., Erwich, J.J., Plösch, T., et al. (2019) The Possible Role of Placental Morphometry in the Detection of Fetal Growth Restriction. Frontiers in Physiology, 9, Article ID: 1884. [Google Scholar] [CrossRef] [PubMed]
[16] Shao, X., Yang, Y., Liu, Y., Wang, Y., Zhao, Y., Yu, X., et al. (2023) Orchestrated Feedback Regulation between Melatonin and Sex Hormones Involving GPER1‐PKA‐CREB Signaling in the Placenta. Journal of Pineal Research, 75, e12913. [Google Scholar] [CrossRef] [PubMed]
[17] Barbouti, A., Varvarousis, D.N. and Kanavaros, P. (2025) The Role of Oxidative Stress-Induced Senescence in the Pathogenesis of Preeclampsia. Antioxidants, 14, Article 529. [Google Scholar] [CrossRef] [PubMed]
[18] Phoswa, W.N. and Khaliq, O.P. (2021) The Role of Oxidative Stress in Hypertensive Disorders of Pregnancy (Preeclampsia, Gestational Hypertension) and Metabolic Disorder of Pregnancy (Gestational Diabetes Mellitus). Oxidative Medicine and Cellular Longevity, 2021, Article ID: 5581570. [Google Scholar] [CrossRef] [PubMed]
[19] Deer, E., Herrock, O., Campbell, N., Cornelius, D., Fitzgerald, S., Amaral, L.M., et al. (2023) The Role of Immune Cells and Mediators in Preeclampsia. Nature Reviews Nephrology, 19, 257-270. [Google Scholar] [CrossRef] [PubMed]
[20] DeVore, G.R. and Polanco, B. (2023) Assessing Maternal Cardiac Function by Obstetricians: Technique and Reference Ranges. American Journal of Obstetrics and Gynecology, 229, 155.e1-155.E18. [Google Scholar] [CrossRef] [PubMed]
[21] Hoermann, H., van Faassen, M., Roeper, M., Hagenbeck, C., Herebian, D., Muller Kobold, A.C., et al. (2024) Association of Fetal Catecholamines with Neonatal Hypoglycemia. JAMA Pediatrics, 178, Article 577. [Google Scholar] [CrossRef] [PubMed]
[22] Khalikova, M., Faistauerová, K. and Lísa, M. (2026) Current Trends in Sample Preparation for Liquid Chromatography—Mass Spectrometry Analysis of Catecholamines and Their Metabolites in Biological Samples. Talanta, 298, Article 128837. [Google Scholar] [CrossRef] 
[23] Bhagat, S., Hanumanthappa, R., Bhokare, K., Datta, N., Vastrad, N., David, M., et al. (2025) Exploring the Vertical Transmission of Exosomes in Diagnostic and Therapeutic Targets for Pregnancy Complications. ACS Biomaterials Science & Engineering, 11, 5157-5185. [Google Scholar] [CrossRef] [PubMed]
[24] Gardias, P. and Bąska, P. (2026) Adrenergic Signaling during Parasitic Infections. Frontiers in Immunology, 16, Article ID: 1691005. [Google Scholar] [CrossRef] 
[25] Perez-Palomar, B., Erdozain, A.M., Erkizia-Santamaría, I., Ortega, J.E. and Meana, J.J. (2023) Maternal Immune Activation Induces Cortical Catecholaminergic Hypofunction and Cognitive Impairments in Offspring. Journal of Neuroimmune Pharmacology, 18, 348-365. [Google Scholar] [CrossRef] [PubMed]
[26] Wu, J., Lin, S., Huang, P., Qiu, L., Jiang, Y., Zhang, Y., et al. (2022) Maternal Anxiety Affects Embryo Implantation via Impairing Adrenergic Receptor Signaling in Decidual Cells. Communications Biology, 5, Article No. 840. [Google Scholar] [CrossRef] [PubMed]
[27] Dagher, M., Cahill, C.M. and Andrews, A.M. (2025) Safety in Treatment: Classical Pharmacotherapeutics and New Avenues for Addressing Maternal Depression and Anxiety during Pregnancy. Pharmacological Reviews, 77, Article 100046. [Google Scholar] [CrossRef] [PubMed]

为你推荐